Variations in urinary 1-hydroxypyrene glucuronide in relation to smoking and the modification effects of GSTM1 and GSTT1

Citation
Yc. Hong et al., Variations in urinary 1-hydroxypyrene glucuronide in relation to smoking and the modification effects of GSTM1 and GSTT1, TOX LETT, 108(2-3), 1999, pp. 217-223
Citations number
26
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGY LETTERS
ISSN journal
03784274 → ACNP
Volume
108
Issue
2-3
Year of publication
1999
Pages
217 - 223
Database
ISI
SICI code
0378-4274(19990905)108:2-3<217:VIU1GI>2.0.ZU;2-T
Abstract
The measurement of the pyrene metabolite, I-hydroxypyrene, in human urine h as been used to assess recent exposure to polycyclic aromatic hydrocarbons (PAH). The objective of this study was to see whether genetic polymorphisms in metabolic enzymes could explain some of the variation in urinary 1-hydr oxypyrene glucuronide (1-OHPG) excretion in relation to smoking. Forty-seve n male hospital workers, who were not occupationally exposed to PAH, partic ipated in this study. The urine samples were analyzed for 1-OHPG utilizing immunoaffinity chromatography and synchronous fluorescence spectroscopy. Th e analysis of GSTM1 and GSTT1 polymorphism was performed by PCR. The 1-OHPG concentration in the urine of the hospital workers was 0.57 +/- 0.85 mu mo l/mol creatinine, and ranged from 0.02 to 5.04 mu mol/mol creatinine. Cigar ette smoking was significantly correlated with urinary 1-OHPG (r = 0.3976, P = 0.0056). The 1-OHPG excretion in GSTM1-deficient smokers was higher tha n that in GSTM1-positive smokers. On the other hand, 1-OHPG excretion was h igher in GSTT1-positive smokers than in GSTT1-deficient smokers. It is impo rtant to note the variability of individual PAH metabolite excretion due to different GSTM1 and GSTT1 genotypes. (C) 1998 Elsevier Science Ireland Ltd . All rights reserved.